Name: Name:1,2,4-Triazine-6-carbonitrile,2-[3,5-dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-2,3,4,5-tetrahydro-3,5-dioxo-
Brand: AABLOCKS
SKU: AA01DOSA
Rating: 90 (10 reviews)

Technical Information

Catalog Number: AA01DOSA

Chemical Name: 1,2,4-Triazine-6-carbonitrile,2-[3,5-dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-2,3,4,5-tetrahydro-3,5-dioxo-

CAS Number: 920509-32-6

Molecular Formula: C17H12Cl2N6O4

Molecular Weight: 435.2210

MDL Number: MFCD26142653

SMILES: N#Cc1nn(c2cc(Cl)c(c(c2)Cl)Oc2n[nH]c(=O)c(c2)C(C)C)c(=O)[nH]c1=O

Properties

Complexity: 878

Covalently-Bonded Unit Count: 1

Defined Atom Stereocenter Count: 0

Defined Bond Stereocenter Count: 0

Formal Charge: 0

Heavy Atom Count: 29

Hydrogen Bond Acceptor Count: 7

Hydrogen Bond Donor Count: 2

Isotope Atom Count: 0

Rotatable Bond Count: 4

Undefined Atom Stereocenter Count: 0

Undefined Bond Stereocenter Count: 0

XLogP3: 2.7

Downstream Synthesis Route

CASUnavailable

920509-32-6

[1]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2007/9913,2007,A1Locationinpatent:Page/Pagecolumn89-90

920509-32-6

920509-35-9

[1]CurrentPatentAssignee:SHANGHAIKUNHENGPHARMACEUTICALTECH;KPCPHARMACEUTICALS,INC.;SHANGHAIKUNHENGPHARMATECH-WO2022/194073,2022,A1Locationinpatent:Page/Pagecolumn13

[2]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2007/9913,2007,A1Locationinpatent:Page/Pagecolumn91

[3]Kelly,MarthaJ.;Pietranico-Cole,Sherrie;Larigan,J.Douglas;Haynes,Nancy-Ellen;Reynolds,CharlesH.;Scott,Nathan;Vermeulen,John;Dvorozniak,Mark;Conde-Knape,Karin;Huang,Kuo-Sen;So,Sung-Sau;Thakkar,Kshitij;Qian,Yimin;Banner,Bruce;Mennona,Frank;Danzi,Sara;Klein,Irwin;Taub,Rebecca;Tilley,Jefferson[JournalofMedicinalChemistry,2014,vol.57,#10,p.3912-3923]

[4]CurrentPatentAssignee:INVENTISBIOCOLTD-WO2020/73974,2020,A1Locationinpatent:Paragraph178;179

[5]CurrentPatentAssignee:ALIGOSTHERAPEUTICSINC-WO2020/227549,2020,A1Locationinpatent:Paragraph00328-00329;00327

[6]CurrentPatentAssignee:SHANGHAIKUNHENGPHARMACEUTICALTECH;KPCPHARMACEUTICALS,INC.;SHANGHAIKUNHENGPHARMATECH-EP4083024,2022,A1Locationinpatent:Paragraph0083-0084

[7]CurrentPatentAssignee:SHANGHAIKUNHENGPHARMACEUTICALTECH;KPCPHARMACEUTICALS,INC.;SHANGHAIKUNHENGPHARMATECH-EP4083024,2022,A1Locationinpatent:Paragraph0083-0084

[8]CurrentPatentAssignee:SHANGHAIKUNHENGPHARMACEUTICALTECH;KPCPHARMACEUTICALS,INC.;SHANGHAIKUNHENGPHARMATECH-WO2022/194073,2022,A1Locationinpatent:Page/Pagecolumn13

[9]CurrentPatentAssignee:SHANGHAIKUNHENGPHARMACEUTICALTECH;KPCPHARMACEUTICALS,INC.;SHANGHAIKUNHENGPHARMATECH-EP4083024,2022,A1Locationinpatent:Paragraph0083-0084

50-00-0

920509-32-6

1133710-89-0

[1]CurrentPatentAssignee:ROCHEHOLDINGAG-US2009/82310,2009,A1Locationinpatent:Page/Pagecolumn5;10

920509-32-6

150109-42-5

1133711-12-2

[1]CurrentPatentAssignee:ROCHEHOLDINGAG-US2009/82310,2009,A1Locationinpatent:Page/Pagecolumn8;14

CASUnavailable

920509-32-6

[1]CurrentPatentAssignee:ROCHEHOLDINGAG;SYNTAPHARMACEUTICALSCORP.-WO2014/43706,2014,A1

[2]CurrentPatentAssignee:ROCHEHOLDINGAG;SYNTAPHARMACEUTICALSCORP.-WO2014/43706,2014,A1

920509-32-6 | 1,2,4-Triazine-6-carbonitrile,2-[3,5-dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-2,3,4,5-tetrahydro-3,5-dioxo-